Tango Therapeutics Inc at TD Cowen Healthcare Conference Transcript
Awesome. Welcome everybody to TD Cowan's forty-sixth annual healthcare conference. My name is Maggie. I'm a member of the TD Cowan team, and I'm pleased to introduce Malta Peters of Tango Therapeutics. Yeah, leave it to the company.
Thank you, Maggie. Thanks for inviting us. We are very happy to, be here and in the next 30 minutes or so, I would like to, show you why we at Tango are super excited about what's coming up, in the year 2026.
We have a very compelling story, to tell, and, a lot of this, excitement comes from, data that we have generated, last year and, the years before.
Woppi Medot, our front runner molecule, a PMT5 inhibitor, is a highly potent and selective PMT5 inhibitor with first and best in class potential.
The molecule is clinically validated. We have received a lot of, tailwind from FDA with respect to potential second line, registration opportunities in pancreatic cancer.
We have also launched, proof of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
